Portal de Periódicos da CAPES

Assessing the economic challenges posed by orphan drugs: A comment on Drummond et al.

2007; Cambridge University Press; Volume: 23; Issue: 3 Linguagem: Inglês

10.1017/s0266462307071012

1471-6348

Christopher McCabe, Aki Tsuchiya, Karl Claxton, James Raftery,

Pharmaceutical studies and practices

To the Editor: In a recent study in this Journal, Drummond and colleagues (5) attempt to address the question “Whether the standard methods of HTA are adequate for assisting decisions on patient access to and funding of orphan drugs” before proposing “a research agenda to help understand the societal value of orphan drugs and issues surrounding their development, funding, and use.”